{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:23:22Z","timestamp":1790493802542,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":102,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811311161","type":"print"},{"value":"9789811311178","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-13-1117-8_5","type":"book-chapter","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T08:34:36Z","timestamp":1537346076000},"page":"77-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["ApoE and Neurodegenerative Diseases in Aging"],"prefix":"10.1007","author":[{"given":"Yuemiao","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"5_CR1","unstructured":"ADI (2016) World Alzheimer report"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.exger.2008.03.010","volume":"43","author":"LS Ang","year":"2008","unstructured":"Ang LS, Cruz RP, Hendel A, Granville DJ (2008) Apolipoprotein E, an important player in longevity and age-related diseases. Exp Gerontol 43:615\u2013622","journal-title":"Exp Gerontol"},{"key":"5_CR3","first-page":"5","volume":"89","author":"SC Arbor","year":"2016","unstructured":"Arbor SC, LaFontaine M, Cumbay M (2016) Amyloid-beta Alzheimer targets\u00a0\u2013 protein processing, lipid rafts, and amyloid-beta pores. Yale J Biol Med 89:5\u201321","journal-title":"Yale J Biol Med"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jalz.2012.02.001","volume":"8","author":"Assoc, A","year":"2012","unstructured":"Assoc, A (2012) 2012 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 8:131\u2013168","journal-title":"Alzheimers Dement"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","volume":"11","author":"Assoc, A","year":"2015","unstructured":"Assoc, A (2015) Alzheimer\u2019s Association report 2015 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 11:332\u2013384","journal-title":"Alzheimers Dement"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","volume":"12","author":"Association, A.s","year":"2016","unstructured":"Association, A.s (2016) 2016 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 12:459\u2013509","journal-title":"Alzheimers Dement"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mce.2014.07.005","volume":"394","author":"Q Bao","year":"2014","unstructured":"Bao Q, Pan J, Qi HF, Wang L, Qian H, Jiang FZ, Shao ZR, Xu FZ, Tao ZP, Ma Q et al (2014) Aging and age-related diseases\u00a0\u2013 from endocrine therapy to target therapy. Mol Cell Endocrinol 394:115\u2013118","journal-title":"Mol Cell Endocrinol"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000095246","volume":"22","author":"L Baum","year":"2006","unstructured":"Baum L, Lam LC, Kwok T, Lee J, Chiu HF, Mok VC, Wong A, Chen X, Cheung WS, Pang CP et al (2006) Apolipoprotein E epsilon4 allele is associated with vascular dementia. Dement Geriatr Cogn Disord 22:301\u2013305","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"7399","key":"5_CR01","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"Robert D. Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV.(n.d.) Nature Volume 485, Issue 7399, 24 May 2012, Pages 512\u2013516","journal-title":"Nature"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0764-4469(00)01274-9","volume":"324","author":"H Blanche","year":"2001","unstructured":"Blanche H, Cabanne L, Sahbatou M, Thomas G (2001) A study of French centenarians: are ACE and APOE associated with longevity? C R Acad Sci III 324:129\u2013135","journal-title":"C R Acad Sci III"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","volume":"286","author":"J Brodbeck","year":"2011","unstructured":"Brodbeck J, McGuire J, Liu ZP, Meyer-Franke A, Balestra ME, Jeong DE, Pleiss M, McComas C, Hess F, Witter D et al (2011) Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors. J Biol Chem 286:17217\u201317226","journal-title":"J Biol Chem"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"GJ Bu","year":"2009","unstructured":"Bu GJ (2009) Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333\u2013344","journal-title":"Nat Rev Neurosci"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1523\/JNEUROSCI.19-12-04867.1999","volume":"19","author":"M Buttini","year":"1999","unstructured":"Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW (1999) Expression of human apolipoprotein E3 or E4 in the brains of Apoe\u2212\/\u2212 mice: isoform-specific effects on neurodegeneration. J Neurosci 19:4867\u20134880","journal-title":"J Neurosci"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1600-0404.2010.01473.x","volume":"124","author":"O Carmona","year":"2011","unstructured":"Carmona O, Masuet C, Santiago O, Alia P, Moral E, Alonso-Magdalena L, Casado V, Arbizu T (2011) Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker? Acta Neurol Scand 124:258\u2013263","journal-title":"Acta Neurol Scand"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"18694","DOI":"10.1073\/pnas.0508254102","volume":"102","author":"SJ Chang","year":"2005","unstructured":"Chang SJ, Ma TR, Miranda RD, Balestra ME, Mahley RW, Huang YD (2005) Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci USA 102:18694\u201318699","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/jnen\/60.4.342","volume":"60","author":"HS Cho","year":"2001","unstructured":"Cho HS, Hyman BT, Greenberg SM, Rebeck GW (2001) Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J Neuropathol Exp Neurol 60:342\u2013349","journal-title":"J Neuropathol Exp Neurol"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1159\/000285166","volume":"29","author":"YF Chuang","year":"2010","unstructured":"Chuang YF, Hayden KM, Norton MC, Tschanz J, Breitner JCS, Welsh-Bohmer KA, Zandi PP, Investigators CC (2010) Association between APOE epsilon 4 allele and vascular dementia: the Cache County Study. Dement Geriatr Cogn 29:248\u2013253","journal-title":"Dement Geriatr Cogn"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neulet.2016.06.032","volume":"628","author":"S Das","year":"2016","unstructured":"Das S, Kaul S, Jyothy A, Munshi A (2016) Association of APOE (E2, E3 and E4) gene variants and lipid levels in ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian population. Neurosci Lett 628:136\u2013141","journal-title":"Neurosci Lett"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1474-9726.2011.00705.x","volume":"10","author":"J Deelen","year":"2011","unstructured":"Deelen J, Beekman M, Uh HW, Helmer Q, Kuningas M, Christiansen L, Kremer D, van der Breggen R, Suchiman HE, Lakenberg N et al (2011) Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. Aging Cell 10:686\u2013698","journal-title":"Aging Cell"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1073\/pnas.0409072102","volume":"102","author":"JC Dodart","year":"2005","unstructured":"Dodart JC, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma IM, Paul SM (2005) Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 102:1211\u20131216","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2009.07.032","volume":"464","author":"J Du","year":"2009","unstructured":"Du J, Chang JL, Guo SX, Zhang Q, Wang Z (2009a) ApoE 4 reduces the expression of A beta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons. Neurosci Lett 464:140\u2013145","journal-title":"Neurosci Lett"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbrc.2009.04.047","volume":"383","author":"J Du","year":"2009","unstructured":"Du J, Zhang L, Liu SB, Zhang C, Huang XQ, Li J, Zhao NM, Wang Z (2009b) PPAR gamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons. Biochem Biophys Res Commun 383:485\u2013490","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1006\/bbrc.1996.1053","volume":"224","author":"R Egensperger","year":"1996","unstructured":"Egensperger R, Bancher C, Kosel S, Jellinger K, Mehraein P, Graeber MB (1996) The apolipoprotein E epsilon 4 allele in Parkinson\u2019s disease with Alzheimer lesions. Biochem Biophys Res Commun 224:484\u2013486","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease\u00a0\u2013 a meta-analysis. Jama-J Am Med Assoc 278:1349\u20131356","journal-title":"Jama-J Am Med Assoc"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"e1005728","DOI":"10.1371\/journal.pgen.1005728","volume":"11","author":"K Fortney","year":"2015","unstructured":"Fortney K, Dobriban E, Garagnani P, Pirazzini C, Monti D, Mari D, Atzmon G, Barzilai N, Franceschi C, Owen AB et al (2015) Genome-wide scan informed by age-related disease identifies loci for exceptional human longevity. PLoS Genet 11:e1005728","journal-title":"PLoS Genet"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1194\/jlr.R800058-JLR200","volume":"50","author":"GS Getz","year":"2009","unstructured":"Getz GS, Reardon CA (2009) Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J Lipid Res 50:S156\u2013S161","journal-title":"J Lipid Res"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1212\/WNL.0b013e3181e074a7","volume":"74","author":"O Ghaffar","year":"2010","unstructured":"Ghaffar O, Reis M, Pennell N, O\u2019Connor P, Feinstein A (2010) APOE epsilon4 and the cognitive genetics of multiple sclerosis. Neurology 74:1611\u20131618","journal-title":"Neurology"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u2013185","journal-title":"Science"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-3940(94)90190-2","volume":"182","author":"J Hardy","year":"1994","unstructured":"Hardy J, Crook R, Prihar G, Roberts G, Raghavan R, Perry R (1994) Senile dementia of the Lewy body type has an apolipoprotein-E Epsilon-4 allele frequency intermediate between controls and Alzheimers-disease. Neurosci Lett 182:1\u20132","journal-title":"Neurosci Lett"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO, Mitani A, Joyner D, Thyssen DH, Bacskai BJ et al (2012) Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid beta peptide. J Neurosci 32:15181\u201315192","journal-title":"J Neurosci"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.ncl.2016.06.009","volume":"34","author":"RA Hickman","year":"2016","unstructured":"Hickman RA, Faustin A, Wisniewski T (2016) Alzheimer disease and its growing epidemic risk factors, biomarkers, and the urgent need for therapeutics. Neurol Clin 34:941","journal-title":"Neurol Clin"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11010-008-0012-2","volume":"326","author":"V Hirsch-Reinshagen","year":"2009","unstructured":"Hirsch-Reinshagen V, Burgess BL, Wellington CL (2009) Why lipids are important for Alzheimer disease? Mol Cell Biochem 326:121\u2013129","journal-title":"Mol Cell Biochem"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D et al (2000a) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 97:2892\u20132897","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","volume":"47","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT (2000b) Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer\u2019s disease model. Ann Neurol 47:739\u2013747","journal-title":"Ann Neurol"},{"issue":"Pt A","key":"5_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","volume":"72","author":"Y Huang","year":"2014","unstructured":"Huang Y, Mahley RW (2014) Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases. Neurobiol Dis 72(Pt A):3\u201312","journal-title":"Neurobiol Dis"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1073\/pnas.151254698","volume":"98","author":"Y Huang","year":"2001","unstructured":"Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW (2001) Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci U S A 98:8838\u20138843","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR36","doi-asserted-by":"publisher","first-page":"A89","DOI":"10.1212\/01.WNL.0000130159.28215.6A","volume":"62","author":"XM Huang","year":"2004","unstructured":"Huang XM, Chen PC, Poole C (2004) APOE epsilon-2 allele associated with higher prevalence of sporadic Parkinson\u2019s disease. Neurology 62:A89\u2013A90","journal-title":"Neurology"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"212ra161","DOI":"10.1126\/scitranslmed.3007000","volume":"5","author":"E Hudry","year":"2013","unstructured":"Hudry E, Dashkoff J, Roe AD, Takeda S, Koffie RM, Hashimoto T, Scheel M, Spires-Jones T, Arbel-Ornath M, Betensky R et al (2013) Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Sci Transl Med 5:212ra161","journal-title":"Sci Transl Med"},{"key":"5_CR38","first-page":"595","volume":"60","author":"AJ Hughes","year":"1993","unstructured":"Hughes AJ, Daniel SE, Lees AJ (1993) The clinical features of Parkinson\u2019s disease in 100 histologically proven cases. Adv Neurol 60:595\u2013599","journal-title":"Adv Neurol"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.proghi.2016.01.001","volume":"51","author":"ASM Hung","year":"2016","unstructured":"Hung ASM, Liang Y, Chow TCH, Tang HC, Wu SLY, Wai MSM, Yew DT (2016) Mutated tau, amyloid and neuroinflammation in Alzheimer disease-a brief review. Prog Histochem Cytochem 51:1\u20138","journal-title":"Prog Histochem Cytochem"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"e59478","DOI":"10.1371\/journal.pone.0059478","volume":"8","author":"S Jain","year":"2013","unstructured":"Jain S, Yoon SY, Leung L, Knoferle J, Huang Y (2013) Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development. PLoS One 8:e59478","journal-title":"PLoS One"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/acel.12362","volume":"14","author":"SC Johnson","year":"2015","unstructured":"Johnson SC, Dong X, Vijg J, Suh Y (2015) Genetic evidence for common pathways in human age-related diseases. Aging Cell 14:809\u2013817","journal-title":"Aging Cell"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1179\/016164103101201968","volume":"25","author":"RN Kalaria","year":"2003","unstructured":"Kalaria RN (2003) Comparison between Alzheimer\u2019s disease and vascular dementia: implications for treatment. Neurol Res 25:661\u2013664","journal-title":"Neurol Res"},{"key":"5_CR43","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Xu HX, Bu GJ (2014) ApoE and A beta in Alzheimer\u2019s disease: accidental encounters or partners? Neuron 81:740\u2013754","journal-title":"Neuron"},{"issue":"Suppl 2","key":"5_CR44","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jnc.13632","volume":"139","author":"E Karran","year":"2016","unstructured":"Karran E, De Strooper B (2016) The amyloid cascade hypothesis: are we poised for success or failure? J Neurochem 139(Suppl 2):237\u2013252","journal-title":"J Neurochem"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/jnnp.57.11.1414","volume":"57","author":"J Kawamata","year":"1994","unstructured":"Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J (1994) Apolipoprotein E polymorphism in Japanese patients with Alzheimer\u2019s disease or vascular dementia. J Neurol Neurosurg Psychiatry 57:1414\u20131416","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-150348","volume":"48","author":"JT Keeney","year":"2015","unstructured":"Keeney JT, Ibrahimi S, Zhao L (2015) Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer\u2019s disease prevention and early intervention. J Alzheimers Dis 48:411\u2013424","journal-title":"J Alzheimers Dis"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.cell.2009.05.042","volume":"137","author":"D Kim","year":"2009","unstructured":"Kim D, Tsai LH (2009) Bridging physiology and pathology in AD. Cell 137:997\u20131000","journal-title":"Cell"},{"key":"5_CR48","doi-asserted-by":"publisher","first-page":"767","DOI":"10.14348\/molcells.2014.0248","volume":"37","author":"J Kim","year":"2014","unstructured":"Kim J, Yoon H, Basak J, Kim J (2014) Apolipoprotein E in synaptic plasticity and Alzheimer\u2019s disease: potential cellular and molecular mechanisms. Mol Cells 37:767\u2013776","journal-title":"Mol Cells"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/brain\/aws127","volume":"135","author":"RM Koffie","year":"2012","unstructured":"Koffie RM, Hashimoto T, Tai HC, Kay KR, Serrano-Pozo A, Joyner D, Hou S, Kopeikina KJ, Frosch MP, Lee VM et al (2012) Apolipoprotein E4 effects in Alzheimer\u2019s disease are mediated by synaptotoxic oligomeric amyloid-beta. Brain 135:2155\u20132168","journal-title":"Brain"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"340ra372","DOI":"10.1126\/scitranslmed.aaf1059","volume":"8","author":"DK Kumar","year":"2016","unstructured":"Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, Lefkowitz A, McColl G, Goldstein LE, Tanzi RE et al (2016) Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease. Sci Transl Med 8:340ra372","journal-title":"Sci Transl Med"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ Ladu","year":"1994","unstructured":"Ladu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE (1994) Isoform-specific binding of apolipoprotein-E to Beta-amyloid. J Biol Chem 269:23403\u201323406","journal-title":"J Biol Chem"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.molmed.2010.07.008","volume":"16","author":"V Leduc","year":"2010","unstructured":"Leduc V, Jasmin-Belanger S, Poirier J (2010) APOE and cholesterol homeostasis in Alzheimer\u2019s disease. Trends Mol Med 16:469\u2013477","journal-title":"Trends Mol Med"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1074\/mcp.M900430-MCP200","volume":"9","author":"Y Lee","year":"2010","unstructured":"Lee Y, Kockx M, Raftery MJ, Jessup W, Griffith R, Kritharides L (2010) Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry. Mol Cell Proteomics 9:1968\u20131981","journal-title":"Mol Cell Proteomics"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1212\/01.WNL.0000128089.53030.AC","volume":"62","author":"YJ Li","year":"2004","unstructured":"Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, Walter JW, Nance MA, Hubble JP, Koller WC et al (2004) Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 62:2005\u20132009","journal-title":"Neurology"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106\u2013118","journal-title":"Nat Rev Neurol"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1074\/jbc.A116.714576","volume":"292","author":"JH Luo","year":"2017","unstructured":"Luo JH, Warmlander SKTS, Graslund A, Abrahams JP (2017) Cross-interactions between the Alzheimer disease amyloid-beta peptide and other amyloid proteins. A further aspect of the amyloid cascade hypothesis (vol 291, pg 16488, 2016). J Biol Chem 292:2046\u20132046","journal-title":"J Biol Chem"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW (1988) Apolipoprotein-E\u00a0\u2013 cholesterol transport protein with expanding role in cell biology. Science 240:622\u2013630","journal-title":"Science"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1073\/pnas.0600549103","volume":"103","author":"RW Mahley","year":"2006","unstructured":"Mahley RW, Weisgraber KH, Huang YD (2006) Apolipoprotein E4: a causative factor and therapeutic target in neuropathology including Alzheimer\u2019s disease. Proc Natl Acad Sci USA 103:5644\u20135651","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12031-016-0839-z","volume":"60","author":"L Mahoney-Sanchez","year":"2016","unstructured":"Mahoney-Sanchez L, Belaidi AA, Bush AI, Ayton S (2016) The complex role of apolipoprotein E in Alzheimer\u2019s disease: an overview and update. J Mol Neurosci 60:325\u2013335","journal-title":"J Mol Neurosci"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1212\/WNL.53.6.1308","volume":"53","author":"MO McCarron","year":"1999","unstructured":"McCarron MO, Delong D, Alberts MJ (1999) APOE genotype as a risk factor for ischemic cerebrovascular disease\u00a0\u2013 a meta-analysis. Neurology 53:1308\u20131311","journal-title":"Neurology"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K (1991) Apolipoprotein-E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimers-disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541:163\u2013166","journal-title":"Brain Res"},{"key":"5_CR62","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","volume":"386","author":"JT O\u2019Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A (2015) Vascular dementia. Lancet 386:1698\u20131706","journal-title":"Lancet"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1600-0404.1999.tb00398.x","volume":"100","author":"RL Oliveri","year":"1999","unstructured":"Oliveri RL, Cittadella R, Sibilia G, Manna I, Valentino P, Gambardella A, Aguglia U, Zappia M, Romeo N, Andreoli V et al (1999) APOE and risk of cognitive impairment in multiple sclerosis. Acta Neurol Scand 100:290\u2013295","journal-title":"Acta Neurol Scand"},{"key":"5_CR64","first-page":"75","volume":"2","author":"JE Pankiewicz","year":"2014","unstructured":"Pankiewicz JE, Guridi M, Kim J, Asuni AA, Sanchez S, Sullivan PM, Holtzman DM, Sadowski MJ (2014) Blocking the apoE\/A beta interaction ameliorates A beta-related pathology in APOE epsilon 2 and epsilon 4 targeted replacement Alzheimer model mice. Acta Neuropathol Commun 2:75","journal-title":"Acta Neuropathol Commun"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/STROKEAHA.107.488866","volume":"39","author":"L Paternoster","year":"2008","unstructured":"Paternoster L, Gonzalez NAM, Lewis S, Sudlow C (2008) Association between apolipoprotein E genotype and carotid intima-media thickness may suggest a specific effect on large artery atherothrombotic stroke. Stroke 39:48\u201354","journal-title":"Stroke"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1177\/1352458509348512","volume":"15","author":"E Portaccio","year":"2009","unstructured":"Portaccio E, Goretti B, Zipoli V, Nacmias B, Stromillo ML, Bartolozzi ML, Siracusa G, Guidi L, Federico A, Sorbi S et al (2009) APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. Mult Scler 15:1489\u20131494","journal-title":"Mult Scler"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"L Puglielli","year":"2003","unstructured":"Puglielli L, Tanzi RE, Kovacs DM (2003) Alzheimer\u2019s disease: the cholesterol connection. Nat Neurosci 6:345\u2013351","journal-title":"Nat Neurosci"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jocn.2011.01.028","volume":"18","author":"T Pulkes","year":"2011","unstructured":"Pulkes T, Papsing C, Mahasirimongkol S, Busabaratana M, Kulkantrakorn K, Tiamkao S (2011) Association between apolipoprotein E genotypes and Parkinson\u2019s disease. J Clin Neurosci 18:1333\u20131335","journal-title":"J Clin Neurosci"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1046\/j.1471-4159.1997.68020760.x","volume":"68","author":"PS Puttfarcken","year":"1997","unstructured":"Puttfarcken PS, Manelli AM, Falduto MT, Getz GS, LaDu MJ (1997) Effect of apolipoprotein E on neurite outgrowth and beta-amyloid-induced toxicity in developing rat primary hippocampal cultures. J Neurochem 68:760\u2013769","journal-title":"J Neurochem"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1073\/pnas.95.18.10914","volume":"95","author":"J Raber","year":"1998","unstructured":"Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley RW, Mucke L (1998) Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci U S A 95:10914\u201310919","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR71","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","volume":"257","author":"SC Rall","year":"1982","unstructured":"Rall SC, Weisgraber KH, Mahley RW (1982) Human apolipoprotein-E\u00a0\u2013 the complete amino-acid-sequence. J Biol Chem 257:4171\u20134178","journal-title":"J Biol Chem"},{"key":"5_CR72","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jneuroim.2007.02.003","volume":"186","author":"SV Ramagopalan","year":"2007","unstructured":"Ramagopalan SV, Deluca GC, Morrison KM, Herrera BM, Dyment DA, Orton S, Bihoreau MT, Degenhardt A, Pugliatti M, Sadovnick AD et al (2007) No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis. J Neuroimmunol 186:156\u2013160","journal-title":"J Neuroimmunol"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2016.10.037","volume":"255","author":"KL Rasmussen","year":"2016","unstructured":"Rasmussen KL (2016) Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: a review. Atherosclerosis 255:145\u2013155","journal-title":"Atherosclerosis"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","volume":"15","author":"R Ricciarelli","year":"2017","unstructured":"Ricciarelli R, Fedele E (2017) The amyloid cascade hypothesis in Alzheimer\u2019s disease: It\u2019s time to change our mind. Curr Neuropharmacol 15:926\u2013935","journal-title":"Curr Neuropharmacol"},{"key":"5_CR75","first-page":"207","volume":"46","author":"GC Roman","year":"2004","unstructured":"Roman GC (2004) Vascular dementia. Advances in nosology, diagnosis, treatment and prevention. Panminerva Med 46:207\u2013215","journal-title":"Panminerva Med"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ et al (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 43:1467\u20131472","journal-title":"Neurology"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ng0194-29","volume":"6","author":"F Schachter","year":"1994","unstructured":"Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6:29\u201332","journal-title":"Nat Genet"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/WNN.0b013e31823380b5","volume":"24","author":"J Shi","year":"2011","unstructured":"Shi J, Tu JL, Gale SD, Baxter L, Vollmer TL, Campagnolo DI, Tyry TM, Zhuang Y, Kuniyoshi SM (2011) APOE epsilon4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis. Cogn Behav Neurol 24:128\u2013133","journal-title":"Cogn Behav Neurol"},{"key":"5_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-291X(74)90882-1","volume":"58","author":"B Shore","year":"1974","unstructured":"Shore B, Shore V (1974) An apolipoprotein preferentially enriched in cholesteryl ester-rich very low density lipoproteins. Biochem Biophys Res Commun 58:1\u20137","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-9-2","volume":"9","author":"LM Tai","year":"2014","unstructured":"Tai LM, Mehra S, Shete V, Estus S, Rebeck GW, Bu GJ, LaDu MJ (2014) Soluble apoE\/A beta complex: mechanism and therapeutic target for APOE4-induced AD risk. Mol Neurodegener 9:2","journal-title":"Mol Neurodegener"},{"key":"5_CR81","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jnr.10221","volume":"68","author":"B Teter","year":"2002","unstructured":"Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM (2002) Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J Neurosci Res 68:331\u2013336","journal-title":"J Neurosci Res"},{"key":"5_CR82","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0003-9993(03)00043-1","volume":"84","author":"I Treger","year":"2003","unstructured":"Treger I, Froom P, Ring H, Friedman G (2003) Association between apolipoprotein E4 and rehabilitation outcome in hospitalized ischemic stroke patients. Arch Phys Med Rehabil 84:973\u2013976","journal-title":"Arch Phys Med Rehabil"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.csbj.2017.05.003","volume":"15","author":"IF Tudorache","year":"2017","unstructured":"Tudorache IF, Trusca VG, Gafencu AV (2017) Apolipoprotein E\u00a0\u2013 a multifunctional protein with implications in various pathologies as a result of its structural features. Comput Struct Biotechnol J 15:359\u2013365","journal-title":"Comput Struct Biotechnol J"},{"key":"5_CR84","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0014-5793(79)80094-0","volume":"97","author":"G Utermann","year":"1979","unstructured":"Utermann G, Beisiegel U (1979) Charge-shift electrophoresis of apolipoproteins from normal humans and patients with Tangier disease. FEBS Lett 97:245\u2013248","journal-title":"FEBS Lett"},{"key":"5_CR85","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1399-0004.1978.tb02101.x","volume":"14","author":"G Utermann","year":"1978","unstructured":"Utermann G, Albrecht G, Steinmetz A (1978) Polymorphism of apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation. Clin Genet 14:351\u2013358","journal-title":"Clin Genet"},{"key":"5_CR86","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1399-0004.1979.tb02028.x","volume":"15","author":"G Utermann","year":"1979","unstructured":"Utermann G, Pruin N, Steinmetz A (1979a) Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet 15:63\u201372","journal-title":"Clin Genet"},{"key":"5_CR87","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1399-0004.1979.tb02027.x","volume":"15","author":"G Utermann","year":"1979","unstructured":"Utermann G, Vogelberg KH, Steinmetz A, Schoenborn W, Pruin N, Jaeschke M, Hees M, Canzler H (1979b) Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet 15:37\u201362","journal-title":"Clin Genet"},{"key":"5_CR88","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2147\/NDT.S84266","volume":"11","author":"V Van Giau","year":"2015","unstructured":"Van Giau V, Bagyinszky E, An SSA, Kim S (2015) Role of apolipoprotein E in neurodegenerative diseases. Neuropsychiatr Dis Treat 11:1723\u20131737","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5_CR89","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, Castellano JM, Garai K, Wang YN, Jiang H, Shah A, Bu GJ, Frieden C, Holtzman DM (2013) ApoE influences amyloid-beta (A beta) clearance despite minimal apoE\/A beta association in physiological conditions. Proc Natl Acad Sci U S A 110:E1807\u2013E1816","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR90","doi-asserted-by":"publisher","first-page":"16983","DOI":"10.1073\/pnas.0608128103","volume":"103","author":"JM Wang","year":"2006","unstructured":"Wang JM, Irwin RW, Brinton RD (2006) Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc Natl Acad Sci U S A 103:16983\u201316988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR91","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.05.048","volume":"26","author":"LK Wei","year":"2017","unstructured":"Wei LK, Au A, Menon S, Griffiths LR, Kooi CW, Irene L, Zhao J, Lee C, Alekseevna AM, Hassan MRA et al (2017) Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and ischemic stroke: meta-analysis. J Stroke Cerebrovasc Dis 26:2482\u20132493","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","volume":"45","author":"KH Weisgraber","year":"1994","unstructured":"Weisgraber KH (1994) Apolipoprotein E: structure-function relationships. Adv Protein Chem 45:249\u2013302","journal-title":"Adv Protein Chem"},{"key":"5_CR93","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1016\/S0021-9258(18)89574-6","volume":"260","author":"DL Williams","year":"1985","unstructured":"Williams DL, Dawson PA, Newman TC, Rudel LL (1985) Apolipoprotein E synthesis in peripheral tissues of nonhuman primates. J Biol Chem 260:2444\u20132451","journal-title":"J Biol Chem"},{"key":"5_CR94","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y (2006) Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci 26:4985\u20134994","journal-title":"J Neurosci"},{"key":"5_CR95","first-page":"3912175","volume":"2016","author":"M Xu","year":"2016","unstructured":"Xu M, Zhao J, Zhang Y, Ma X, Dai Q, Zhi H, Wang B, Wang L (2016) Apolipoprotein E gene variants and risk of coronary heart disease: a meta-analysis. Biomed Res Int 2016:3912175","journal-title":"Biomed Res Int"},{"key":"5_CR96","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jns.2011.05.040","volume":"308","author":"C Xuan","year":"2011","unstructured":"Xuan C, Zhang BB, Li M, Deng KF, Yang T, Zhang XE (2011) No association between APOE epsilon 4 allele and multiple sclerosis susceptibility: a meta-analysis from 5472 cases and 4727 controls. J Neurol Sci 308:110\u2013116","journal-title":"J Neurol Sci"},{"key":"5_CR97","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2012.02.031","volume":"514","author":"YW Yin","year":"2012","unstructured":"Yin YW, Li JC, Wang JZ, Li BH, Pi Y, Yang QW, Fang CQ, Gao CY, Zhang LL (2012) Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis. Neurosci Lett 514:6\u201311","journal-title":"Neurosci Lett"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"41774","DOI":"10.1074\/jbc.M112.407957","volume":"287","author":"KL Youmans","year":"2012","unstructured":"Youmans KL, Tai LM, Nwabuisi-Heath E, Jungbauer L, Kanekiyo T, Gan M, Kim J, Eimer WA, Estus S, Rebeck GW et al (2012) APOE4-specific changes in A beta accumulation in a new transgenic mouse model of Alzheimer disease. J Biol Chem 287:41774\u201341786","journal-title":"J Biol Chem"},{"key":"5_CR99","doi-asserted-by":"crossref","unstructured":"Zephir H (2018) Progress in understanding the pathophysiology of multiple sclerosis. Rev Neurol (Paris)","DOI":"10.1016\/j.neurol.2018.03.006"},{"key":"5_CR100","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0047-6374(98)00067-0","volume":"104","author":"JG Zhang","year":"1998","unstructured":"Zhang JG, Ma YX, Wang CF, Lu PF, Zhen SB, Gu NF, Feng GY, He L (1998) Apolipoprotein E and longevity among Han Chinese population. Mech Ageing Dev 104:159\u2013167","journal-title":"Mech Ageing Dev"},{"key":"5_CR101","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1191\/1352458504ms1010oa","volume":"10","author":"JN Zwemmer","year":"2004","unstructured":"Zwemmer JN, van Veen T, van Winsen L, van Kamp GJ, Barkhof F, Polman CH, Uitdehaag BM (2004) No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis. Mult Scler 10:272\u2013277","journal-title":"Mult Scler"}],"container-title":["Advances in Experimental Medicine and Biology","Aging and Aging-Related Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-1117-8_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T00:06:25Z","timestamp":1649808385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-13-1117-8_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811311161","9789811311178"],"references-count":102,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-1117-8_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"20 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}